Design and synthesis of potential antichagasic agents

Vol 2, 2022 - 153267
Poster
Favoritar este trabajo
¿Cómo citar este artículo?
Resúmenes

Chagas disease(CD) is a common anthropozoonosis in Latin America and its transmission occurs through the parasite called Trypanosoma cruzi. CD presents serious public health problems for many countries in Latin America. However, due to globalization and the legal and illegal immigration of people from endemic countries, several cases have been reported in other countries, such as the United States, Canada, Japan, and Australia, as well as in several European countries. Currently, in the 21 countries considered endemic, approximately 75 million people are exposed to the infection, six million are infected and more than 30,000 new cases arise each year. Faced with the need to search for molecules with antitrypanosomal activity, we have designed molecules based on nitric oxide releasers (NO) and enzymatic inhibition of CYP51 and Fe-SOD. Taking this into account, six compounds were synthesized and are now being analyzed for potential in vitro antitrypanosomal activity.

¡Comparte tus ideas o preguntas con los autores!

¿Sabías que el mayor estímulo en el desarrollo científico y cultural es la curiosidad? ¡Deje sus preguntas o sugerencias al autor!

Inicia sesión para interactuar

¿Tiene alguna pregunta o sugerencia? ¡Comparte tus comentarios con los autores!

Instituciones
  • 1 University of Sao Paulo
  • 2 Universidade de São Paulo
  • 3 Universidade Estadual de Campinas
Eje Temático
  • 2. Medicinal Chemistry of Synthetic Compounds
Palabras Clave
drug design
bioisosterism
Molecular Hydridation
antichagasic agent
Enzyme inhibition